"Regulatory surveillance will continue to be intensified in the coming weeks and non-compliance will be dealt strictly with actions, including cancellation of licenses, penalties, and prosecution under applicable laws. This comes in the backdrop of several domestic pharmaceutical companies, including Sun Pharma, Dr Reddys, Alkem, Torrent, Cipla, Zydus Lifesciences and Glenmark, launching generic versions of GLP-1 drug semaglutide following its patent expiry in India this month
Enhanced IL-10 signaling potentiates oxidative phosphorylation and inhibits glucose uptake, further suppressing glycolysis (50, 51)
Are there supplements I should avoid, or be taking, due to this drug
doi:10.12659/msm.882125 Farag A, Abass W, Qassem H